相关实验视频
Updated: Jun 14, 2026

16:38
Bridging the Bio-Electronic Interface with Biofabrication
Published on: June 6, 2012
16.8K
含酸的生物相容桑膜表现出强大的抗病毒活性,对罩和非罩病毒
Alba Cano-Vicent1, Alberto Tuñón-Molina1, Miguel Martí1
1Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain.
International journal of molecular sciences
|August 12, 2023
概括
这项研究开发了一种新的奇托桑/酸薄膜,显示出显著的广泛抗病毒特性. 这种生物相容的薄膜实现了高水平的病毒失活,显示了生物医学应用的前景.
科学领域:
- 生物材料科学 生物材料科学
- 病毒学 病毒学
- 纳米技术 纳米技术
背景情况:
- 奇托是一种多功能生物聚合物,具有固有的抗微生物特性.
- 在生物医学应用中,开发有效的抗病毒材料仍然是一个关键的挑战.
- 酸可以修改基托桑的特性,潜在地提高其功能.
研究的目的:
- 用一种基于酸的溶液来制备和特征化基托桑薄膜.
- 为了评估开发的基托薄膜的体外生物相容性.
- 评估基托桑/酸薄膜对包裹和非包裹病毒的广泛抗病毒疗效.
主要方法:
- 溶剂造技术用于片的制备.
- 基托桑薄膜是用15.49%的酸溶液 (10%v/v) 配制的.
- 在体外生物相容性测试使用人类角质细胞 HaCaT 细胞.
- 对phi6 (包裹) 和MS2 (非包裹) 菌体进行了抗病毒活性评估.
主要成果:
- 奇托/酸薄膜与HaCaT细胞具有很好的生物相容性.
- 观察到显著的病毒无活化:在phi6中高达99.98%和MS2.2中高达99.92%.
- 这些片显示出强大的抗病毒活性,对包裹病毒和非包裹病毒都具有强大的抗病毒活性.
结论:
- 素/酸薄膜是生物相容的,具有强大的广泛抗病毒能力.
- 这些发现凸显了这种材料在生物医学应用中的潜力.
- 开发的薄膜代表了一个有前途的生物降解抗病毒解决方案.
更多相关视频
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

